Microvascular angina: a women's affair?

Microvascular Angina (Cardiac Syndrome X)

The prevalence of microvascular angina is estimated to be up to 30% of stable angina patients with non-obstructive coronary arteries. 19% of women presenting with acute coronary syndrome, 30% of women presenting with unstable angina, 9.1% of women with non-STelevation myocardial infarction and 10% of women with ST-elevation myocardial infarction were determined to have normal or nonobstructive ...

Microvascular Angina (Cardiac Syndrome X)

The prevalence of microvascular angina is estimated to be up to 30% of stable angina patients with nonobstructive coronary arteries. 19% of women presenting with acute coronary syndrome, 30% of women presenting with unstable angina, 9.1% of women with non-ST-elevation myocardial infarction and 10% of women with ST-elevation myocardial infarction were determined to have normal or non-obstructive...

Peripheral vascular endothelial dysfunction in patients with angina pectoris and normal coronary arteriograms.

OBJECTIVES We sought to determine endothelium-dependent vasodilator function in the brachial artery of patients with microvascular angina pectoris. BACKGROUND Previous studies suggest the presence of endothelial dysfunction of the coronary microcirculation in patients with microvascular angina pectoris. It is not known whether endothelial dysfunction in these patients is a generalized process...

Therapeutic approach to microvascular angina (syndrome X)

Correlation between coronary microvascular function and angina status in patients with stable microvascular angina.

BACKGROUND Classical anti-ischemic drugs are the first-line form of treatment in patients with microvascular angina (MVA), but they often fail to achieve a satisfactory control of angina symptoms. It is unknown whether there is any relation between improvement of angina status and changes in microvascular function induced by classical anti-ischemic drugs in MVA patients. AIM To assess whether...